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Abstract
Aging is the primary risk factor of neurodegenerative disorders such as Alzheimer’s disease (AD). However, the molecular
events occurring during brain aging are extremely complex and still largely unknown. For a better understanding of these
age-associated modifications, animal models as close as possible to humans are needed. We thus analyzed the
transcriptome of the temporal cortex of the primate Microcebus murinus using human oligonucleotide microarrays
(Affymetrix). Gene expression profiles were assessed in the temporal cortex of 6 young adults, 10 healthy old animals and 2
old, ‘‘AD-like’’ animals that presented ß-amyloid plaques and cortical atrophy, which are pathognomonic signs of AD in
humans. Gene expression data of the 14,911 genes that were detected in at least 3 samples were analyzed. By SAM
(significance analysis of microarrays), we identified 47 genes that discriminated young from healthy old and ‘‘AD-like’’
animals. These findings were confirmed by principal component analysis (PCA). ANOVA of the expression data from the
three groups identified 695 genes (including the 47 genes previously identified by SAM and PCA) with significant changes
of expression in old and ‘‘AD-like’’ in comparison to young animals. About one third of these genes showed similar changes
of expression in healthy aging and in ‘‘AD-like’’ animals, whereas more than two thirds showed opposite changes in these
two groups in comparison to young animals. Hierarchical clustering analysis of the 695 markers indicated that each group
had distinct expression profiles which characterized each group, especially the ‘‘AD-like’’ group. Functional categorization
showed that most of the genes that were up-regulated in healthy old animals and down-regulated in ‘‘AD-like’’ animals
belonged to metabolic pathways, particularly protein synthesis. These data suggest the existence of compensatory
mechanisms during physiological brain aging that disappear in ‘‘AD-like’’ animals. These results open the way to new
exploration of physiological and ‘‘AD-like’’ aging in primates.
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Introduction
In EU, life expectancy is about 83 years for women and 76 for
men, and it is expected to further increase. This trend will have
major economic and social impacts due to the prevalence of age-
related diseases. ‘‘Normal’’ age-related cognitive changes have
been traditionally ascribed to cell loss in the brain. However,
experimental evidence is now accumulating suggesting that
synaptic rearrangement, rather than cell loss, causes critical age-
related brain changes [1–3]. Most elderly individuals experience
no major, or very limited functional impairment thus highlighting
the human brain ability to compensate for potential cognitive
decline. In other words, although aging may be a cause of
cognitive alteration and is the main risk factor for Alzheimer’s
disease (AD) [4], they are clearly two separated processes. AD is
not accelerated aging and therefore it is important to be able to
distinguish physiological from pathological aging. The discovery of
genes, which are differentially expressed in normally aging
and AD brains, could provide a tool to identify biomarkers [5]
that can differentiate between physiological and pathological
brain aging and which might help to identify new therapeutic
targets.
Non-human primates constitute a valuable tool for studies on
brain aging because of their lifespan and their closeness to
humans. We propose to take advantage of the grey mouse lemur,
Microcebus murinus, which is a pro-simian primate whose lifespan in
captivity can reach 12–13 years. In grey mouse lemurs, the 50%
survival point occurs at 60 months (i.e., at the age of 5 years) and
allows defining the adult and elderly part of the population [6].
Animals older than 5 years of age show desynchronized biological
rhythms, motor activity and sleep-wake cycles [6], [7]. Impor-
tantly, during aging, some lemurs develop, like humans, pathog-
nomonic signs of AD such as presence of ß-amyloid plaques [8]
witha prevalence of 5% (data unpublished), tau proteinaggregation
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present the most severe neuropathology associated with a pro-
gressive and consistent pattern of neuronal-glial alterations [10].
Moreover, this animal model can be used to investigate cognitive
deficits [11–14].
We thus analyzed the gene expression profiles in the temporal
cortex of young adult, healthy elderly and old lemurs with ß-
amyloid plaques (‘‘AD-like’’ group) in order to identify genes
involved in physiological and pathological aging. Since Microcebus
murinus microarrays do not exist, we decided to use Affymetrix
human genome chips since recent studies have illustrated the
feasibility of detecting non-human primate brain transcripts
using human genome chips [15–18]. We chose the temporal
cortex because this region is connected to the hippocampus and
to the frontal cortex, which are critical structures for learning
and memory and are altered in AD. Analysis of the microarray
data indicates that the temporal cortex has different gene
expression profiles in young, old and ‘‘AD-like’’ animals and that
several genes are differentially expressed in healthy aged and
‘‘AD-like’’ animals. Specifically, genes involved in metabolism,
particularly in protein synthesis, were up-regulated during
physiological brain aging, whereas in ‘‘AD-like’’ brains genes
involved in protein synthesis and nuclear activity were often
down-regulated.
Results
Histological characterization of young adult, elderly and
‘‘AD-like’’ brain in Microcebus murinus
Before investigating the possible differences of gene expression
in the temporal cortex of young adult, elderly and ‘‘AD-like’’ grey
mouse lemurs, we compared the anatomical shape of the brains
from the three groups (Fig. 1). We did not observe any difference
Figure 1. Brain sections and ß-amyloid plaques detection. Brain sagittal sections, localized at L 2.80 and L 3.00 from the median line according
to the stereotaxic atlas of Microcebus murinus [40]. The contour of the brain slice was drawn with the Mercator software (ExploraNova, La Rochelle,
France). A. Young adult lemur (N
br 986) B. Healthy old lemur (N
br 43) C. AD-like old lemur (N
br 896). Frontal cortex (FC), occipital cortex (OC),
cerebellum (C), lateral ventricle (LV). Amyloid deposits representative of the two ‘‘AD-like’’ lemurs, in the frontal cortex (D) and the occipital cortex (E).
Higher magnification showing labeling of ß-amyloid plaques (F and G).
doi:10.1371/journal.pone.0012770.g001
Table 1. Genes detected in the temporal cortex of Microcebus
murinus.
Age (yr) Males Females Number of detected genes
Young 160.1 2 4 8914.6761482.68
Old 7.862.9 3 7 9456.2061378.93
AD-like 1063.3 0 2 8259.00645.25
All 5 13 9142.6761349.59
Transcripts detected in temporal cortex samples from young adult, old and
‘‘AD-like’’ animals by hybridization to the Affymetrix HG-U133 Plus 2.00 Array.
The ages and the detected genes were expressed as mean 6 SD.
doi:10.1371/journal.pone.0012770.t001
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lateral ventricles between young (Fig. 1A) and healthy old animals
(Fig. 1B). Conversely, in ‘‘AD-like’’ animals, we detected cortical
atrophy, lateral ventricle dilatation (Fig. 1C) and ß-amyloid
plaques (Fig. 1D,1E, 1F and 1G).
Detection of transcripts with Affymetrix human genome
chips
In order to assess the feasibility of using human genome arrays
to study gene expression in the temporal cortex of Microcebus
murinus, we first sequenced about 150 genes of the grey mouse
lemur and compared them with their human homologues. They
all presented a percentage of identity with their human
counterparts that varied from 88% to 96% (data not shown).
These results supported our choice of using the Affymetrix HG-
U133 Plus 2.0 human microarray to investigate the pattern of gene
expression in the temporal cortex of young adult, old and ‘‘AD-
like’’ grey mouse lemurs (Table 1). The overall rate of genes with a
‘‘present’’ detection call (P) for each group was about 20%, with a
slightly higher number of genes (9,45661,378) detected in healthy
aged animals, and a slightly lower number of genes (8,259645)
expressed in the ‘‘AD-like’’ group in comparison to the young
adult group (8,91461,482). Moreover, we noticed a lower SD in
Figure 2. Schematic representation of the different analyses. Microarray data were filtered to detect the present transcripts (P). Then the
filtered data were processed by SAM. ANOVA was performed with the (P) data and with the data sorted by SAM and the 47 P selected genes were
analyzed by PCA. Finally, the 47 and the 695 genes were investigated by clustering and were classified by functional categories.
doi:10.1371/journal.pone.0012770.g002
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expression within this group. In human somatic tissues, which also
included brain samples, the mean rate of genes with P call was
21278 (range: 7142–28389). Hence, although the percentage of
genes detected by the HG-U133 Plus 2.0 microarray was lower in
grey mouse lemur samples, it was still within the range of values
observed in human samples.
Analysis of age-dependent gene expression changes in
the temporal cortex
In order to characterize the expression profiles of adult, old and
‘‘AD-like’’ temporal cortex of Microcebus murinus, we first filtered
the raw data (see Figure 2 for a schematic description for the
analytical approach) and kept only the transcripts (n=14,911)
which had a ‘‘P’’ call in at least 3 samples. We then used the
Significance Analysis of Microarrays (SAM) method to identify
genes that were differentially expressed when comparing the three
groups together or when assessing only healthy elderly and young
or ‘‘AD-like’’ animals. The comparison of the three groups
identified 1,055 transcripts with a false discovery rate (FDR) up to
45%. Since this risk of false positive was high, we assessed the
significance of the changes in gene expression by ANOVA. The
ANOVA analysis with a cut off at p,0.05 identified 695 genes
with a significant gene expression change (i.e. 4.7% of expressed
genes) and this number was reduced to 152 when the cut off
was set at p,0.01 (i.e. 1% of the expressed genes) (Fig. 2 and
Table S1).
Table 2. Number of genes identified by SAM as differentially
regulated in the temporal cortex of old animals.
Delta Significant genes FDR%
0.76 6 0.00
0.74 14 6.84
0.64 30 9.58
0.64 44 10.88
0.56 53 12.65
0.56 70 13.68
0.49 83 17.31
0.43 105 20.06
0.43 116 20.64
0.42 148 21.35
0.41 177 22.18
0.40 213 23.83
0.39 233 24.25
0.36 334 27.24
0.33 399 31.08
0.30 532 34.74
0.28 605 37.67
0.25 710 41.41
Delta table: number of genes with significant expression change in brain of
aged lemurs detected by SAM analysis of expression data from temporal cortex
samples of 10 healthy old lemurs and 6 young adults. The delta parameter is
the threshold used to select genes that are significantly differentially expressed.
The false discovery rate (FDR, expressed in %) is defined by the number of false
positive genes divided by the number of genes identified as differentially
expressed. Higher delta values lower the FDR but also reduce the number of
selected genes. Delta table.
doi:10.1371/journal.pone.0012770.t002
Table 3. Genes identified by SAM as differentially regulated
in the temporal cortex of old animals.
Probesets Name FC p-value Function
205061_s_at EXOSC9 1.77 **** Prot. Synthesis
0200936_at RPL8 1.58 *** Prot. Synthesis
200817_x_at RPS10 1.56 *** Prot. Synthesis
226131_s_at RPS16 1.59 *** Prot. Synthesis
211487_x_at RPS17 1.70 *** Prot. Synthesis
212270_x_at RPL17 1.54 *** Prot. Synthesis
214003_x_at RPS20 1.65 **** Prot. Synthesis
200834_s_at RPS21 1.65 *** Prot. Synthesis
218830_at RPL26L1 1.59 ** Prot. Synthesis
219762_s_at RPL36 1.85 **** Prot. Synthesis
212863_x_at CTBP1 1.47 ** Prot. Synthesis
200757_s_at CALU 1.37 **** Prot. Maturation
222578_s_at UBE1DC1 1.58 *** Proteolysis
201322_at ATP5B 1.38 ** Mitoch. Metabolism
207507_s_at ATP5G3 1.56 * Mitoch. Metabolism
200818_at ATP5O 1.49 ** Mitoch. Metabolism
201226_at NDUFB8 1.63 ** Mitoch. Metabolism
201227_s_at NDUFB8 1.65 *** Mitoch. Metabolism
35201_at HNRPL 1.34 * RNA related
218117_at RBX1 1.59 *** Nuclear factor
226465_s_at SON 1.72 *** Nuclear factor
204009_s_at KRAS 1.38 *** Epigenetic
207721_x_at HINT1 1.58 ** Epigenetic
1555961_a_at HINT1 1.68 *** Epigenetic
224415_s_at HINT2 1.47 *** Epigenetic
222540_s_at HBXAP 1.38 *** Epigenetic
204745_x_at MT1G 2.04 *** Cell cycle regulation
206461_x_at MT1H 2.02 *** Cell cycle regulation
218206_x_at SCAND1 1.45 ***** Cell proliferation
208864_s_at TXN 1.56 *** Cell proliferation
205352_at SERPINI1 1.50 *** Neurogenesis
232520_s_at NSFL1C 1.48 *** Synapse
202670_at MAP2K1 1.59 **** Kinase
226888_at CSNK1G1 1.35 ***** Kinase
217848_s_at PP 1.69 ***** Phosphatase
205809_s_at WASL 1.80 ** Transduction
219392_x_at FLJ11029 1.36 *** Unknown
229302_at MGC33926 1.46 ***** Unknown
230076_at FLJ10156 1.47 **** Unknown
225956_at LOC153222 1.54 * Unknown
218859_s_at C20orf6 1.88 ** Unknown
241993_x_at — 1.90 ***** Unknown
218011_at — 1.57 ***** Unknown
List of 44 transcripts detected with a delta value set at 0.64 and a FDR of about
10%. Genes were classified according to their function: metabolism, nuclear
activity, neurotransmission–synaptic plasticity, signaling pathways and
unknown functions. P-value of the Student’s t-test: 0.05 (*); 0.01 (**); 0.05 (***);
0.001 (****); 0.0005 (*****); FC: fold change. The 6 genes detected with 0% FDR
were noted in bold.
doi:10.1371/journal.pone.0012770.t003
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from the young and the old group by SAM sorted 44 transcripts
(FDR about 10%, Table 2), which were significantly up-regulated
(fold change between 1.37 and 3.82) in healthy aging animals
(Table 3). These genes are mainly involved in protein synthesis,
mitochondrial metabolism, and nuclear regulation. Conversely,
comparison of the gene expression data from ‘‘AD-like’’ and
healthy old animals indicated that 40 genes were strongly down-
regulated (fold change between 21.6 and 23.3) in the ‘‘AD-like’’
group (Tables 4 and 5), with the exception of GK001 that was up-
regulated. Among these genes, only a fraction plays a role in
protein synthesis and nuclear regulation.
When for the comparison of the three groups a more stringent
delta cutoff was chosen (from 0.058 to 0.03) the number of genes
identified as differentially expressed in the three groups was
reduced to 47 and among them were included the 28 genes that
had been already sorted by the two SAM analyses using the data
from young and healthy old animals or healthy old and both ‘‘AD-
like’’ animals (Tables 6 and 7).
Principal component analysis of the 47 genes, which were
identified as differentially expressed in the three groups by SAM,
confirmed that they could clearly separate young, healthy old and
‘‘AD-like’’ animals (Fig. 3). The first component represented the
gene expression signature with a score of 64.59% of the variance
in the three groups. Healthy aged animals could be differentiated
from the young ones with a score of 43.85% (Fig. 3A, axis 1), and
the ‘‘AD-like’’ group could be distinguished from the healthy old
group with a score of 20.74% (Fig. 3A, axis 2). Genes with a high
correlation coefficient were considered to be important for
discriminating the three groups (Fig. 3B). Genes located to the
left of axis 1 characterized the group of healthy aged animals.
Most of them are involved in protein synthesis (RPS16, 17, 19, 20,
21, RPL26L1 and 36), mitochondrial metabolism (NADH dehydro-
genase complex, NDUFB8) or in the regulation of transcription
(SCAND1, HNRPL, HINT1-2, KRAS). Genes located at the top of
Table 4. Number of genes identified by SAM as differentially
regulated in ‘‘AD-like’’ temporal cortex samples.
Delta Significant genes FDR%
0.46 2 0.00
0.38 27 17.42
0. 36 37 19.06
0.35 40 21.16
0.28 52 23.51
0.24 84 30.79
0.24 94 29.51
0.23 110 30.78
0.21 172 35.27
0.20 208 35.72
0.20 244 36.61
0.19 341 37.78
0.19 460 40.07
0.17 569 42.15
0.17 765 43.89
0.16 836 45.28
0.15 968 48.92
0.14 1073 51.27
Delta table: number of genes with significant expression changes in aged
animals detected by SAM analysis of expression data from temporal cortex
samples from 2 ‘‘AD-like’’ lemurs and 10 healthy old animals.
doi:10.1371/journal.pone.0012770.t004
Table 5. Genes identified by SAM as differentially regulated
in ‘‘AD-like’’ temporal cortex samples.
Probesets Name FC p-value Function
211487_x_at RPS17 22.07 *** Prot. synthesis
200834_s_at RPS21 21.60 **** Prot. synthesis
225672_at GOLGA2 21.88 * Prot. maturation
38710_at OTUB1 21.51 * Proteolysis
35201_at HNRPL 21.61 ****** RNA related
203752_s_at JUND 21.86 * Transcription
227772_at LATS1 21.98 * Transcription
200055_at TAF10 21.90 *** RNA related
209431_s_at ZNF278 22.53 ****** Nuclear factor
218977_s_at SECP43 22.71 ****** Nuclear factor
48580_at CXXC1 22.84 * Nuclear factor
223132_s_at TRIM8 21.74 * Nuclear factor
208676_s_at PA2G4 21.90 * Cell cycle regulation
218034_at TTC11 21.65 ** Apoptosis
219888_at SPAG4 23.34 ** Cytoskeleton
203069_at SV2A 21.64 ** Synapses
225058_at GPR108 22.23 ** Synapses
209982_s_at NRXN2 22.59 *** Synapses
229309_at ADRB1 21.79 * Synapses
206397_x_at GDF1 22.01 * Growth factor
210185_at CACNB1 21.70 * Ion channel
222432_s_at GK001 2.65 ****** Signal. Transd.
213108_at CAMK2A 21.65 ****** Kinase
215903_s_at MAST2 22.22 ***** Kinase
228302_x_at CaMKIINalpha 23.09 *** Kinase
209945_s_at GSK3B 21.97 * Kinase
200822_x_at TPI1 21.87 *** Phosphate metabol.
33197_3_at GAPD 21.33 * Phosphate metabol.
225519_at PPP4R2 22.08 ****** Phosphatase
227325_at LOC255783 25.11 ****** Unknown
228935_at LOC283400 25.20 ****** Unknown
210408_s_at CPNE6 22.06 ****** Unknown
217033_x_at — 21.68 ***** Unknown
1554429_a_at DMWD 21.87 **** Unknown
219392_x_at FLJ11029 21.79 **** Unknown
48106_at — 22.01 *** Unknown
219910_at HYPE 21.57 * Unknown
207435_s_at SRRM2 21.97 * Unknown
218089_at C20orf4 21.92 * Unknown
218429_s_at FLJ11286 21.72 * Unknown
List of the 40 transcripts sorted using a delta set at 0.35 and a FDR of 21%. All
were down-regulated in AD, but for GK001. Genes were classified according to
their function: metabolism, nuclear activity, neurotransmission–synaptic
plasticity, signaling pathways and unknown functions. FC: fold change; P value:
0.05 (*); 0.01 (**); 0.05 (***); 0.001 (****); 0.0005 (*****). The 2 genes detected
with 0% FDR were noted in bold.
doi:10.1371/journal.pone.0012770.t005
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play a role in neurotransmission (STXBP1), intracellular trafficking
(SNAG1), regulation of transcription (ZBTB11) or in epigenetic
processes (HAT1). However, also genes, which are not yet reported
as having brain-related functions, such as SPAP1, which is
expressed in mature lymphocyte B cells, contributed to delineate
the ‘‘AD-like’’ group. Calumenin (CALU), a protein which is
involved in the regulation of vitamin K-dependent carboxylation
of multiple amino-terminal glutamate residues and normally is
present at very low levels in the brain, also was up-regulated in the
2 ‘‘AD-like’’ animals. Others encode proteins that are detected in
neurofibrillary tangles, such as Ubiquilin-1 (UBQLN1), which
promotes the accumulation of uncleaved PSEN1 and PSEN2 that
are involved in AD pathology.
The 47 genes sorted by SAM were included in the 695 genes
identified by ANOVA as differentially expressed in the three
groups. Among these 695 genes, the expression of 350 was
modified by age, the expression of 427 by the ‘‘AD-like’’ pathology
(Table 8) and some by both. Among the 350 genes modified by
age, 209 were up-regulated and 141 down-regulated, and among
the 427 genes modified by the pathology, 250 were up-regulated
and 177 down-regulated. Moreover, 28% of the genes that were
differentially regulated in ‘‘AD-like’’ samples showed a similar
change in expression also in healthy old animals, whereas 72%
showed an opposite change of expression in comparison to the
healthy old group. We also analyzed the expression data by taking
into account only the females. In this case the number of
transcripts with significant changes was higher: 1,079 instead of
695 because of less variance due to a better homogeneity of the
populations.
Finally, hierarchical clustering indicated that each group had a
distinct profile whatever the statistical test (SAM (Fig. 4) or
ANOVA (Fig. 5)) used to sort and select the genes and that each
profile was homogenous within the specific group, particularly in
the ‘‘AD-like’’ animals. Hierarchical clustering identified clusters
of genes that were down-regulated in old and up-regulated in
‘‘AD-like’’ animals and genes, which were up-regulated in young
adults and down-regulated in old and ‘‘AD-like’’ animals, in good
agreement with the PCA data and also with the ANOVA analysis
that showed opposite changes (Fig. 4II; 5II) and similar changes
(Fig. 4 I; 5III) in gene expression.
Functional categorization and sexually dimorphic
changes in aged Microcebus murinus males and females
By assessing the relative changes in expression within gene
ontology categories, we could classify the differentially expressed
genes according to their cellular functions and distribute them in 4
main modules: 1- Brain plasticity; 2- Signaling pathways; 3-
Metabolism and protein synthesis; 4- Nuclear activity (Fig. 6 and
Table S2_gene functional categorization). Most of the genes that
Table 6. SAM analysis of the expression data from the three groups.
Probesets Name
FC
A/Y p-value
FC
AD/Y p-value
FC
AD/A p- value Functions
A 226131_s_at RPS16 1.59 *** 1.19 NS 21.34 * prot synthesis
214003_x_at RPS20 1.65 **** 1.03 NS 21.60 *** prot synthesis
218830_at RPL26L1 1.59 *** 1.26 * 21.26 * prot synthesis
219762_s_at RPL36 1.85 **** 21.02 NS 21.88 * prot synthesis
200757_s_at CALU 1.37 ***** 21.07 * 21.47 ***** prot maturation
201227_s_at NDUFB8 1.65 **** 1.20 ** 21.37 **** mitoch metabol.
218206_x_at SCAND1 1.45 ***** 21.04 NS 21.51 *** cell prolif.
207721_x_at HINT1 1.58 *** 1.13 NS 21.40 NS Epigenetic
224415_s_at HINT2 1.47 *** 21.04 NS 21.53 ***** Epigenetic
222540_s_at HBXAP 1.38 *** 1.09 NS 21.27 ** Epigenetic
204009_s_at KRAS 1.38 *** 1.04 NS 21.32 * Epigenetic
202670_at MAP2K1 1.59 ***** 1.21 NS 21.32 NS Kinase
217848_s_at PP 1.69 ***** 1.34 *** 21.26 * Phosphatase
230076_at FLJ10156 1.47 ***** 1.10 NS 21.34 *** Unknown
241993_x_at — 1.90 **** 1.35 NS 21.41 NS Unknown
218011_at — 1.57 ***** 1.09 NS 21.45 NS Unknown
B 223132_s_at TRIM8 21.06 NS 21.85 * 21.74 * nuclear fact.
222432_s_at GK001 21.19 NS 2.23 ****** 2.65 ***** signal transd.
213108_at CAMK2A 1.42 * 21.16 **** 21.65 ***** Kinase
209945_s_at GSK3B 1.43 * 21.38 NS 21.97 * Kinase
C 211487_x_at RPS17 1.70 **** 21.22 NS 22.07 *** prot synthesis
200834_s_at RPS21 1.65 **** 21.03 NS 21.60 **** prot synthesis
35201_at HNRPL 1.34 * 21.20 * 21.61 ***** RNA related
219392_x_at FLJ11029 1.36 *** 21.32 NS 21.79 **** Unknown
Genes with significant expression changes identified when data from the cortex samples of young (Y), healthy aged (A) and ‘‘AD-like’’ (AD) were compared. FC: Fold
Change. These genes have been already sorted as regulated by age (see Table 3); B: genes already identified as regulated by AD (Table 5); C: genes regulated by age and
by AD (Table 3 and 5).
doi:10.1371/journal.pone.0012770.t006
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animals (especially those involved in protein synthesis) belonged to
the ‘‘metabolism and protein synthesis’’ module (Fig. 6A, module
3a). Nuclear factors (Fig. 6A, module 4a) were differentially
expressed particularly in the ‘‘AD-like’’ group. Analysis of the data
from the 2 females only showed that the general profiles were
maintained when compared with the data from all animals
(Fig. 6B). Nevertheless, the number of genes that were up-
regulated with age was higher, whereas the number of down-
regulated genes involved in signaling transduction (Fig. 6B,
module 2b), metabolism (Fig. 6B, module 3a) and in epigenetic
regulations (Fig. 6B, module 4e) was lower.
Discussion
Microcebus murinus is a useful primate model of cerebral aging
and AD. We already showed that, not only they display
pathognomonic lesions for AD and as observed in humans, both
lemurs with AD-like pathology presented cortical atrophy. Recent
studies have shown that brain measurement by MRI could be an
important biomarker of degeneration like in the case of AD
[19,20]. They also represent a tool for anti-amyloid vaccination
studies [21], MRI studies [10] and for developing cognitive tests
[12,14]. Therefore, to further develop the potentialities of this
model, we wanted to identify in the temporal cortex of Microcebus
murinus modifications in gene expression that were associated with
physiological or pathological aging. Using human genome
microarrays the overall rate of gene detection was about 20%.
This value could appear to be rather low, but it has to be
compared with other heterologous (Rhesus monkey with human
microarrays) or homologous (human with human microarray)
studies where only 30–35% and 30–40% of genes were detected
([18]; JDV, personal communication). Our results also confirm
earlier works [15–18] that human chips can be used in non-human
primates.
Among more than 14,000 genes, we have identified 695 genes
(around 4.9%) with significant expression changes in young, aged
and ‘‘AD-like’’ animals. Analysis of the cortex transcriptome from
human brain samples at different ages indicates that the expression
of about 400 genes among 11,000 (around 3.6%) is significantly
changed [22]. Our results are in the same order of magnitude.
We then compared the list of genes that changed in the human
frontal cortex sorted by Lu et coll. (2004) with the genes changing
in the lemurian temporal cortex. We found 13 common genes (out
of 150) and also 58 (out of 150) that belong to the same family and
have similar biological function (e.g. VAMP1/VAMP2 or
Synapsin II and synapsin IIb). Most of the genes that are
differentially expressed in both works appeared to be involved in
the synaptic transmission (8/15), Ca
2+ homeostasis (5/10), cAMP
signalling (2/2)) and in transcription (6/8). In the study by Lu and
coll. the expression of these genes was modified by age, whereas in
our study, they are modified by age and/or by pathology.
The same applies to the fold changes that varied between 1.5
and 3. Moreover, analysis of the microarray data indicates that
Table 7. SAM analysis of the expression data from the three groups.
Probesets Name
FC
A/Y p-value
FC
AD/Y p-value
FC
AD/A p- value Functions
200029_at RPL19 1.69 *** 1.07 NS 21.58 NS prot synthesis
222991_s_at UBQLN1 21.27 NS 1.61 ** 2.04 *** Proteolysis
204528_s_at NAP1L1 1.09 NS 2.15 ****** 2.34 ***** RNA related
213470_s_at HNRPH1 21.52 *** 21.45 * 1.05 NS RNA related
204847_at ZBTB11 1.34 ** 2.17 ****** 1.62 ***** nuclear fact.
203138_at HAT1 1.17 NS 2.14 ** 1.83 ** Epigenetic
203845_at PCAF 1.13 NS 1.93 NS 1.71 NS Epigenetic
202260_s_at STXBP1 1.08 NS 1.50 ****** 1.40 ***** Synapse
214441_at STX6 21.67 ***** 21.50 ** 1.12 NS Synapse
232520_s_at NSFL1C 1.48 **** 1.20 ** 21.23 * Synapse
226683_at SNAG1 1.01 NS 1.51 ****** 1.50 ***** Synapse
205352_at SERPINI1 1.50 *** 1.64 * 1.09 NS Neurogenes.
222960_at CACNA1H 22.04 ****** 21.81 * 1.13 NS Ion channel
223208_at KCTD10 21.86 *** 1.52 ****** 2.83 ***** Ion channel
211302_s_at PDE4B 22.29 *** 24.68 *** 22.05 NS Phosphatase
1563674_at SPAP1 1.68 NS 4.78 *** 2.84 ** Phosphatase
218021_at DHRS4 21.49 ***** 1.10 NS 1.64 ** Dehydrogen
229302_at MGC33926 1.46 ****** 1.28 *** 21.14 * Unknown
65635_at FLJ21865 21.30 *** 21.43 *** 21.10 NS Unknown
215672_s_at KIAA0828 21.72 ****** 21.66 NS 1.04 NS Unknown
48106_at — 21.18 NS 22.37 **** 22.01 *** Unknown
240835_at — 1.16 NS 2.26 ****** 1.95 ***** Unknown
1553705_a_at — 21.50 *** 21.07 NS 1.41 *** Unknown
Genes with significant expression changes identified when data from the cortex samples of young (Y), healthy aged (A) and ‘‘AD-like’’ (AD) were compared. FC: Fold
Change. These genes have been identified by SAM using the data from the three groups.
doi:10.1371/journal.pone.0012770.t007
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has a distinctive gene expression profile in the temporal cortex, a
structure involved in integrative functions such as memory.
Previous studies have already concluded that the expression of
many genes is modified during aging (reviewed in [2,23,24].
Specific profiles in relation with age were observed in human brain
[22,25] and in Rhesus monkey brain, particularly in the corpus
callosum [18] and in the frontal cortex [25]. Interestingly, each
brain region of adult or healthy elderly subjects had a distinct gene
expression profile [26–28]. Altered gene expression was also
observed between healthy elderly individuals and AD patients, for
review [29], particularly in the hippocampus [30,31] and in
neurons of several brain structures [27].
Our results support the hypothesis that the events occurring
during physiological brain aging and AD development are distinct.
However, an important issue is to understand the transition from
physiological to pathological brain aging which leads to neurode-
generative disorders. We observed that many of the genes up-
regulated in healthy aged animals are involved in protein synthesis
such as the genes coding for ribosomal proteins. These results
support the idea that physiological aging, at least in the brain, is
associated with permanent compensatory effects via increased
protein synthesis. Conversely, these genes were down-regulated in
the 2 ‘‘AD-like’’ animals, indicating a failure to compensate a
decline in the metabolic activity in the brain of animals with
amyloid deposits. Moreover, the expression of UBQLN1,a n
ubiquitin-like protein that plays a role in the regulation of the
degradation of proteins by proteasome [32], was significantly
decreased in both ‘‘AD-like’’ animals. This observation is
important as accumulation of misfolded proteins, which are not
degraded by the proteasome, may be involved in the development
of neurodegenerative diseases. The expression of other genes that
are related to the regulation of neural plasticity, an important
process involved in brain aging [3,33], also was changed in ‘‘AD-
like’’ animals in comparison to healthy old ones. Particularly,
GRIN1, the NR1 subunit of the NMDA glutamate receptor, and
GRIA1, a subunit of the AMPA glutamate receptor, which activate
pathways involved in the induction of long-term potentiation
(LTP) were markedly down-regulated. AD-related pathologic
processes lead to synaptic loss and dysfunction, particularly of
glutamatergic transmission [34,35] that can cause inhibition of
LTP [36] as it has been shown also in rodents following acute
treatment with Ab oligomers [37]. Moreover, recent data have
also demonstrated that changes in the expression of nuclear
proteins, which induce epigenetic modifications of chromatin, play
an important role in regulating synaptic plasticity and memory
processes [38]. In our study, we observed that several genes
implicated in epigenetic processes and transcription, such as
histone acetyltransferases (HAT1, PCAF), histidine triad nucleotide
binding proteins (HINT1, HINT2) and the cAMP responsive
element binding protein (CREB1), were down-regulated during
physiological and pathological brain aging. Conversely, KRAS and
HBXAP, which mediates nucleosome assembly and chromatin
remodeling, were up-regulated in healthy aged Microcebus murinus.
Finally, the expression of CLU (APOJ, Clusterin), which is
considered as a risk factor for AD [39,40] was significantly
increased in both ‘‘AD-like’’ animals.
Our data also indicate that changes in gene profiles during aging
in Microcebus murinus temporal cortex might show gender-specificity,
Figure 3. Principal component analysis of the 47 transcripts that are differentially regulated in aging or ‘‘AD-like’’ brain detected
by SAM. A. Projection of the individuals shows that healthy aged animals can be discriminated from the young ones (axis 1), and ‘‘AD-like’’ can be
differentiated from healthy old animals (axis 2). B. Projection of the genes. Genes located to the left of axis 1 characterize healthy aged animals,
whereas genes located at the top of axis 2 characterize the ‘‘AD-like’’ group. Young (Y), aged (A) and ‘‘AD-like’’ (AD) animals.
doi:10.1371/journal.pone.0012770.g003
Table 8. Genes that are differentially regulated during
physiological or pathological aging sorted by ANOVA.
Comparison Young vs Old AD-like vs Old
Up-regulation 209 250
Down-regulation 141 177
All 350 427
doi:10.1371/journal.pone.0012770.t008
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the entire life. This observation needs, however, to be confirmed
since both ‘‘AD-like’’ animals were females. Nevertheless, sexual
dimorphism in gene expression in aging human brain has been
reported by Berchtold et al. [28] and in primate brain by Reinius et
al. [41], whereas Lu and colleagues [22] did not evidence significant
gender differences in the transcriptomic profiles of the human
frontal cortex.
Figure 4. Transcriptional profiles in the temporal cortex of Microcebus murinus. Hierarchical clustering obtained with the 47 genes sorted by
SAM. The transcriptional profiles of the temporal cortex of the 18 Microcebus murinus (i.e., 6 young adults (Yg), 10 old lemurs (Old) and 2 ‘‘AD-like’’
(AD)) showed three distinct profiles for the 3 groups. Each profile could be separated in three distinct regions which were conserved in the three
groups. (A) Dendogram and clustering showing that the animals were clustered by age or by pathology. (B) Hierarchical clustering of lemurs
according to age and pathology. The clusters show that the expression of some genes in ‘‘AD-like’’ lemurs is similar to that in young animals. The
profiles of healthy elderly animals are drastically different from those of the two ‘‘AD-like’’ lemurs. In the three different parts: I- genes that are down-
regulated in aging and in ‘‘AD-like’’ animals; II- genes that are up-regulated with young adults but are down-regulated in ‘‘AD-like’’ animals; III- genes
that are down-regulated in old and up-regulated in ‘‘AD-like’’ animals. Red: over-expressed genes; green: down-regulated genes; black: genes without
expression changes.
doi:10.1371/journal.pone.0012770.g004
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murinus as a valuable non-human primate model for studying
molecular brain changes in relation with age and neurodegener-
ative diseases such as AD.
Materials and Methods
Animals
The Microcebus murinus animals were all born in captivity in our
breeding colony (CECEMA, University of Montpellier 2). They
were divided into three groups: the first (young animals) included
six 1 year/old adults (4 females and 2 males), the second (healthy
old animals) included ten 8 year/old animals (7 females and 3
males), and the third (‘‘AD-like’’ animals) two old females with
cerebral ß-amyloid plaques. About 5% of old lemurs in our colony
develop ß-amyloid plaques in the brain (unpublished data).
Animals were euthanized with 150 mg/Kg ketamine. Animal
care was in accordance with institutional guidelines and the animal
protocol was approved by the Ethic Committee, Comite ´R e ´gional
d’Ethique pour l’Expe ´rimentation Animale - Languedoc Roussil-
lon (authorization #CE-LR-0816, 2008) in accordance with the
European Community Council directives of November 24, 1986.
Brain samples preparation
After euthanasia, each brain was cut in half along the midline.
The right hemisphere was used for the microarray experiments
and the left one for immunohistological experiments. For trans-
criptional analysis, the right hemisphere was dissected and cortex
samples, weighing 25–35 mg, were flash-frozen and stored at
280uC until use. The left hemisphere was fixed in paraformal-
dehyde and embedded in paraffin as previously described [8,14]
and 6 mm serial sagittal sections were prepared.
Immunohistochemistry
Presence of amyloid-ß-42 (Aß42) peptide aggregates was assessed
using the rabbit polyclonal FCA3542 antibody (Calbiochem,
Merck-bio, Germany). Sections were deparaffinized and hydrated
through ethanol gradient. After formic acid pretreatment, sections
were pre-incubated with 10% goat serum in Tris-buffered saline for
30 min. Then, sections were incubated with anti-Aß42 antibodies
(1:1000) at 4uC overnight. Immunological complexes were detected
with biotinylated immunoglobulins (1:1000) and horseradish
peroxidase-labelled avidin (Vector Laboratories, Burlingame,
VT). Immunoreactivity was revealed with 0.005% diaminobenzi-
dine tetrahydrochloride (DAB, 0.35 mg/mL, Sigma, St Louis,
MO). The primary antibody was omitted in the negative control
and sections from Microcebus murinus brain specimens known to
contain ß-amyloid plaques were used as positive controls. The
Microcebus murinus brain atlas was used to localize the brain area of
each section [42].
RNA isolation and Affymetrix GeneChip processing
Total RNA was extracted from each temporal cortex sample
(25–35 mg) using the RNeasy mini kit (Qiagen, Santa Clarina,
CA) according to the manufacturer’s protocol. The quality of each
purified RNA sample was checked with a NanoDrop Agilent
BioAnalyzer (Agilent Technologies, Santa Clara, CA). An average
of 2 mg of total RNA from each cortex sample was prepared for
hybridization with Affymetrix HG-U133 Plus 2.00 GeneChip
(Santa Clara, CA) according to the manufacturer’s protocol. This
microarray contains 54,656 probes corresponding to 47,400
human transcripts. At the end of the experiment, the hybridized
probes were scanned at a resolution of 3 mm in a confocal scanner
(Affymetrix GeneChip Scanner 3000 7G). Affymetrix microarrays
were processed in the Microarray Core Facility of the Institute of
Research of Biotherapy, CHRU-INSERM-UM1 Montpellier
(http://irb.chu-montpellier.fr/).
Affymetrix GeneChip data analysis and filtering
Data were normalized with the GeneChip Operating Software
(GCOS) algorithms. Then, the converted digital intensity values
were stored as image data files and converted into cell intensity
files using the Microarray Affymetrix Software 5.0 (MAS 5).
MAS5 labels each transcript as ‘‘present’’ (P), ‘‘marginal’’ (M) or
‘‘absent’’ (A) by taking into account the average difference value
calculated between the perfect match (PM) and the mismatch
(MM) as detailed in the Affymetrix Genechip procedure (www.
Affymetrix.com). A p-value risk was associated with the signal
intensity. For each gene, the mean signal expression and standard
deviation (SD) were calculated for each group. The fold change
was determined by the ratio between old and young, and between
Figure 5. Transcriptional profiles in the temporal cortex of
Microcebus murinus. Hierarchical clustering obtained with the 695
genes sorted by ANOVA. The transcriptional profiles of the 18
Microcebus murinus (i.e., 6 young adults (Yg), 10 old lemurs (Old) and
2 ‘‘AD-like’’ (AD)) showed 3 distinct regions: I- genes that are up-
regulated in ‘‘AD-like’’ temporal cortex; II- genes that are down-
regulated in ‘‘AD-like’’ temporal cortex and preferentially up-regulated
in aged cortex; III- genes that are down-regulated in ‘‘AD-like’’ and
preferentially up-regulated in young adult cortex. In red are shown
genes that are over-expressed, in green genes that are under-expressed
and in black genes without expression changes.
doi:10.1371/journal.pone.0012770.g005
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during physiological and pathological aging, respectively. All
primary expression data files (*.cel) and (*.xls) are available at the
authors’ web site (http://www.mmdn.univ-montp2.fr/) and at
GEO/NCBI (provisional accession number GSE21779). All steps
were conducted according to the MIAME (Minimum Information
About a Microarray Experiment) checklist [43].
Detection of genes that were differently expressed in the
three groups
To identify genes differently expressed in relation with brain
aging or pathology, filtered data were analyzed with the SAM
(Significance Analysis of Microarrays) method [44], which
uses permutations of repeated measurements to protect against
non-normal data distribution. For that purpose, each group was
compared to the other groups using 1,000 permutations. Because
each animal may show intrinsic individual variability, the
threshold for determining the rate of change was set at 1.5.
SAM calculates the false discovery rate (FDR) with a q-value
according to the delta cutoffs. The statistical significance of the
genes was also investigated by Student t-test or by ANOVA with
the ‘‘R’’ software. Finally, to construct a predictive model of the
changes observed, a projection by principal component analysis
(PCA) was carried out.
Gene profiling
The gene expression profile of each group was established using
the Cluster and Treeview software programs [45]. These analyses
Figure 6. Gene changes in relation to their cellular function identified by gene ontology. The 695 genes sorted by ANOVA were classified
into four main modules: 1- genes involved in brain plasticity [1a-neurotransmission, 1b-neurogenesis, 1c-adhesion and extracellular matrix,
1d-cytoskeleton]; 2- genes involved in transduction and signaling [2a-ion channels, 2b-kinases, 2c-phosphatases, 2d-transferases and 2e-growth
factors]; 3- genes involved in metabolism and catabolism [3a-protein synthesis and maturation, 3b-proteolysis, 3c-glucidic and lipid metabolism and
3d-mitochondrial metabolism]; 4- genes involved in nuclear activity [4a-nuclear factors, 4b-transcription regulation, 4c-cell cycle regulation,
4d-apoptosis and 4e- epigenetic control]. Red bars represent genes that are up-regulated and the green bars genes that are down-regulated in the
temporal cortex of aging animals; hatched red bars represent genes that are up-regulated and hatched green bars genes that are down-regulated in the
temporal cortex of‘‘AD-like’’ lemurs. A. Classification withmales and females together. B. Classificationwithfemales only. Inaginganimals genes involved
in protein synthesis were more frequently up-regulated (red arrow), and the most important differences between aging and ‘‘AD-like’’ profiles concerned
genes that have a role in protein synthesis and nuclear activity (blue arrows).The major differences between A and B are indicated by black arrows.
doi:10.1371/journal.pone.0012770.g006
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significantly associated with brain aging.
Functional categorization of the identified genes
To categorize the genes that were differentially expressed, we
used two approaches: the first approach consisted in searching the
literature using PubMed (NCBI), GenBank (www.ncbi.nlm.nih.
gov/Genbank/), or specific databases such as Gene Expression
Omnibus (GEO) (www.ncbi.nlm.nih.gov/geo/), the KEEG path-
way database (www.genome.jp/kegg/pathway.html), UniProt
(www.uniprot.org), and the Allen Brain Atlas (www.brain-
map.org; http://humancortex.alleninstitute.org/has/human/docs.
html). The second approach consisted in assigning genes to
biological and molecular functions using the hierarchical database
of the Gene Ontology (GO) consortium and EASE (Expression
Analysis Systematic Explorer software; www.geneontology.org/).
Finally, PathwayArchitect (Stratagene, Genome Exploration, UK)
and IPA-Ingenuity (www.ingenuity.com) allowed us to build
interactive networks.
Supporting Information
Table S1 Genes sorted by anova
Found at: doi:10.1371/journal.pone.0012770.s001 (0.05 MB
XLS)
Table S2 Gene functional categorization
Found at: doi:10.1371/journal.pone.0012770.s002 (0.19 MB
XLS)
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